Showing results (81-90 of 224) with videos related to
Sort By:
Pageof 23
Rapid Communications in Mass Spectrometry : RCM|January 31, 2008
Enhanced resolution triple-quadrupole mass spectrometry for ultra-sensitive and quantitative analysis of the investigational anticancer agent EO9 (apaziquone) and its metabolite EO5a in human and dog plasma to support (pre)-clinical studies of EOquin given intravesicallyLiia D Vainchtein, Hilde Rosing, Dorla Mirejovsky, et al.Analytical Biochemistry|June 16, 2009
The bioanalysis of trastuzumab in human serum using precipitate-enhanced ellipsometryCarola W N Damen, Han Speijer, Wim T Hermens, et al.Journal of Pharmaceutical and Biomedical Analysis|July 31, 2025
LC-MS/MS method development and validation for novel targeted anticancer therapies adagrasib, capmatinib, ensartinib, entrectinib, larotrectinib, lorlatinib, pralsetinib, selpercatinib and sotorasibMarinda Meertens, L Daniëlle de Jong, Niels de Vries, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 10, 2022
Development and validation of a high-performance liquid chromatography tandem mass spectrometry method for the quantification of the antiparasitic and antifungal drug amphotericin B in human skin tissueIgnace C Roseboom, Bas Thijssen, Hilde Rosing, et al.Molecular and Cellular Biology|December 6, 2006
Multidrug transporter ABCG2/breast cancer resistance protein secretes riboflavin (vitamin B2) into milkAntonius E van Herwaarden, Els Wagenaar, Gracia Merino, et al.Bioanalysis|September 25, 2020
Bottom-up sample preparation for the LC-MS/MS quantification of anti-cancer monoclonal antibodies in bio matricesKaren Am de Jong, Suse J van Breugel, Michel Jx Hillebrand, et al.Journal of Pharmaceutical and Biomedical Analysis|July 9, 2021
Simultaneous quantification of abemaciclib and its active metabolites in human and mouse plasma by UHPLC-MS/MSAlejandra Martínez-Chávez, Matthijs M Tibben, Karen A M de Jong, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 1, 2021
The role of drug efflux and uptake transporters ABCB1 (P-gp), ABCG2 (BCRP) and OATP1A/1B and of CYP3A4 in the pharmacokinetics of the CDK inhibitor milciclibAlejandra Martínez-Chávez, Jelle Broeders, Maria C Lebre, et al.Molecular Pharmaceutics|July 23, 2019
P-glycoprotein Limits Ribociclib Brain Exposure and CYP3A4 Restricts Its Oral BioavailabilityAlejandra Martínez-Chávez, Stéphanie van Hoppe, Hilde Rosing, et al.Cancer Chemotherapy and Pharmacology|May 20, 2026
Transfer of trastuzumab and pertuzumab into human breast milk: a case reportPauline L M Buitelaar, Dick Pluim, Sandy Hanssens, et al.Pageof 23